This protocol describes procedures for the collection of blood samples for the intent of
determining genetic contribution to the safety and efficacy of CPT/FU/LV.
- Participation in studies employing treatment with irinotecan and a signed informed
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: